BioMarin Pharmaceutical Inc (BMRN) Operating cash flow 2016–2025
BioMarin Pharmaceutical Inc (BMRN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$828.0MFY2025 · since FY2016: -$227.8M → $828.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $828.0M | +44.5% |
| FY2024 | $572.8M | +259.7% |
| FY2023 | $159.3M | -9.5% |
| FY2022 | $175.9M | -42.2% |
| FY2021 | $304.5M | +256.7% |
| FY2020 | $85.4M | +76.9% |
| FY2019 | $48.3M | +138.8% |
| FY2018 | $20.2M | +330.8% |
| FY2017 | -$8.8M | +96.2% |
| FY2016 | -$227.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice